Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Net Income towards Common Stockholders: 2011-2025

Historic Net Income towards Common Stockholders for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $16.7 million.

  • Mimedx Group's Net Income towards Common Stockholders rose 112.59% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year decrease of 48.57%. This contributed to the annual value of $42.0 million for FY2024, which is 24.73% down from last year.
  • As of Q3 2025, Mimedx Group's Net Income towards Common Stockholders stood at $16.7 million, which was up 74.13% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's Net Income towards Common Stockholders peaked at $44.8 million during Q4 2023, and registered a low of -$12.5 million during Q2 2022.
  • Over the past 3 years, Mimedx Group's median Net Income towards Common Stockholders value was $7.9 million (recorded in 2024), while the average stood at $11.9 million.
  • Examining YoY changes over the last 5 years, Mimedx Group's Net Income towards Common Stockholders showed a top increase of 681.83% in 2022 and a maximum decrease of 281.44% in 2022.
  • Quarterly analysis of 5 years shows Mimedx Group's Net Income towards Common Stockholders stood at -$1.4 million in 2021, then skyrocketed by 681.83% to $8.1 million in 2022, then skyrocketed by 451.13% to $44.8 million in 2023, then plummeted by 83.41% to $7.4 million in 2024, then soared by 112.59% to $16.7 million in 2025.
  • Its Net Income towards Common Stockholders stands at $16.7 million for Q3 2025, versus $9.6 million for Q2 2025 and $7.0 million for Q1 2025.